Adverum Biotechnologies, Inc. revenue breakdown overview

Adverum Biotechnologies, Inc. revenue for the last year amounted to 3.60 M USD, the most of which — 3.60 M USD — came from its highest performing source at the moment, Gene Therapeutics, the year earlier bringing 7.50 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Adverum Biotechnologies, Inc. 3.60 M USD, and the year before that — 7.50 M USD.